Releases - Zealand Pharma A/S

View:
 

Found press releases

 

Zealand Pharma A/S - Interim report for Q1 2013 (un-audited)

5/15/2013 2:35 AM EST
Zealand Pharma A/S
Company Announcement

Zealand Pharma A/S - Interim report for Q1 2013 (un-audited)

Copenhagen, 2013-05-15 08:35 CEST (GLOBE NEWSWIRE) --

Company Announcement
No. 14/2013

- Fully in line with expectations, net result for the quarter was DKK -57
(EUR -8) million

- Cash and securities of DKK 441 (EUR 59) million on 31 March 2013

- Financial outlook for 2013 retained

- European...

Zealand announces amendments to its Articles of Association

5/8/2013 8:30 AM EST
Zealand Pharma A/S
Company Announcement

Zealand announces amendments to its Articles of Association

Copenhagen, 2013-05-08 14:30 CEST (GLOBE NEWSWIRE) -- Zealand Pharma A/S
(NASDAQ OMX Copenhagen: ZEAL) (“Zealand”) informs that the company’s Articles
of Association have been amended.

The amendments to the Articles of Association are entailed by the decision at
the company’s Annual General Meeting, held on 30...

Notice of Zealand’s Interim Report for Q1 2013

5/8/2013 4:21 AM EST
Zealand Pharma A/S
Investor News

Notice of Zealand’s Interim Report for Q1 2013

Copenhagen, 2013-05-08 10:21 CEST (GLOBE NEWSWIRE) -- Zealand Pharma A/S
(NASDAQ OMX Copenhagen: ZEAL) (“Zealand”) a Danish biotechnology company
dedicated to the discovery and development of novel peptide drugs, informs that
its interim report for the first quarter of 2013 in accordance with the
Financial Calendar will be...

Zealand Pharma announces Sanofi’s ongoing commitment to the Lantus®/Lyxumia® sin...

5/2/2013 1:38 AM EST
Zealand Pharma A/S
Company Announcement

Zealand Pharma announces Sanofi’s ongoing commitment to the Lantus®/Lyxumia®
single combination program

Priority for Phase III initiation assigned by Sanofi to the Fixed-Ratio
combination product

Copenhagen, 2013-05-02 07:38 CEST (GLOBE NEWSWIRE) -- Zealand Pharma A/S
(NASDAQ OMX Copenhagen: ZEAL) (“Zealand”) announces that its licensing partner
Sanofi (EURONEXT:SAN...

Zealand Pharma A/S - Passing of Annual General Meeting

4/30/2013 10:30 AM EST
Zealand Pharma A/S
Company Announcement

Zealand Pharma A/S - Passing of Annual General Meeting

Copenhagen, 2013-04-30 16:30 CEST (GLOBE NEWSWIRE) --
-- All proposals from the Board of Directors were adopted
-- Following the General Meeting, the Board of Directors constituted itself
with Daniël J. Ellens as new Chairman and Jørgen Lindegaard as new Vice
Chairman

Today, Zealand Pharma A/S (NASDAQ OMX...

Zealand Pharma A/S convenes for the Annual General Meeting 2013

4/4/2013 9:57 AM EST
Zealand Pharma A/S
Company Announcement

Zealand Pharma A/S convenes for the Annual General Meeting 2013

Copenhagen, 2013-04-04 15:57 CEST (GLOBE NEWSWIRE) --

Company Announcement
No. 10/2013

Copenhagen, 4 April 2013 - Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL)
(“Zealand”), a Danish biotechnology company dedicated to the innovation and
development of peptide drugs, convenes for the Company’s ordinary...

Zealand Pharma announces change in management

3/15/2013 4:06 AM EST
Zealand Pharma A/S
Company Announcement

Zealand Pharma announces change in management

Copenhagen, 2013-03-15 09:06 CET (GLOBE NEWSWIRE) -- Zealand Pharma A/S
(“Zealand”) (NASDAQ OMX Copenhagen: ZEAL), a Danish biotechnology company
dedicated to the discovery and development of novel peptide drugs, announces
that Christian Grøndahl, Executive Vice President and Chief Scientific Officer
will leave the company to...

Zealand Pharma A/S announces Full Year results and Annual Report for 2012

3/14/2013 3:32 AM EST
Zealand Pharma A/S
Company Announcement

Zealand Pharma A/S announces Full Year results and Annual Report for 2012

Copenhagen, 2013-03-14 08:32 CET (GLOBE NEWSWIRE) -- - First Zealand invented
medicine, Lyxumia® for Type 2 diabetes now approved in Europe and under
regulatory review globally

- Revenues of DKK 224 (EUR 30) million and net results of DKK 36 (EUR 5)
million for 2012 were the best ever in the...

Zealand launches new corporate branding platform and logo

3/14/2013 3:00 AM EST
Zealand Pharma A/S
Press release

Zealand launches new corporate branding platform and logo

Copenhagen, 2013-03-14 08:00 CET (GLOBE NEWSWIRE) -- Zealand Pharma A/S (NASDAQ
OMX Copenhagen: ZEAL) announces the launch of a new corporate branding platform
and company logo which as of today can be viewed on the company’s website at
www.zealandpharma.com.

Commenting on the new company branding, David Solomon,...

CORRECTION: Notice of Zealand Pharma Full Year results and publication of the An...

3/8/2013 8:54 AM EST
Zealand Pharma A/S
Investor News

CORRECTION: Notice of Zealand Pharma Full Year results and publication of the
Annual Report for 2012

Copenhagen, 2013-03-08 14:54 CET (GLOBE NEWSWIRE) --
style="font-size:11pt;font-family:Arial, Helvetica, sans-serif;">Replacement
announcement correcting the date of the conference call to Thursday 14
March.

Zealand Pharma A/S

RSS